Skip to main content
European Cannabis Institute · Est. 2026 · Lisbon, Portugal

Europe's cannabis GMP training and certification institute

Professional certification, industry intelligence and practitioner training for the European medical cannabis sector. Built by practitioners, for practitioners.

Explore the Academy Take the Industry Survey
€2.4B
European Cannabis Market 2026
24+
European Markets Mapped
4
Certification Pathways
Q3 2026
Knowledge Centre Launch
European Cannabis Institute institutional seal — advancing pharmaceutical standards in cannabis
Why ECI exists

The cannabis industry is pharmaceuticalising.

01
Built for cannabis operatorsEvery course, certification and framework is designed around the specific regulatory, scientific and operational realities of licensed cannabis facilities across Europe.
02
Practitioner-led contentEvery course, assessment and framework is authored by professionals with direct experience of pharmaceutical manufacturing and cannabis regulation — not adapted from generic compliance training.
03
Document-led deliveryCourses produce real outputs — protocols, templates and gap assessments. Practitioners leave with tools that function in live compliance environments from day one.
04
Scientific and regulatory breadthGMP and validation expertise combined with PhD-level pharmacognosy and regulatory science — the full compliance and scientific spectrum under one institute.
"The distance between a cannabis licence and a GMP-compliant operation is where most European facilities currently sit. Closing it is the defining challenge — and the defining opportunity — of the next three years."
— Gary McPolin, Founder, European Cannabis Institute

The European medical cannabis market is maturing rapidly. National licensing requirements, EU GMP obligations and increasingly active regulatory inspection are setting a bar that demands real pharmaceutical competence.

ECI provides the knowledge infrastructure to close that gap. Systematically. Credibly. At scale.

About ECI
Where to begin

Cannabis GMP training, certification and intelligence

01 · Academy and Certification

Cannabis GMP and validation certification
Four certification pathways covering GMP, pharmaceutical science, validation and cultivation. Online, self-paced, scenario-based assessment. Certifications are panel-assessed and industry-recognised.
Explore pathways →

02 · Knowledge Centre

Cannabis GMP articles and regulatory intelligence
Evidence-based articles on GMP, validation and regulatory science. Jurisdiction-by-jurisdiction regulatory updates across European markets. Research informing the ECI curriculum.
Visit the Knowledge Centre →

03 · Intelligence

European cannabis compliance survey and regulatory map
The State of European Cannabis Compliance survey is open now. The regulatory map covers 24+ markets. The inaugural intelligence report publishes Q4 2026.
Explore intelligence →
ECI Knowledge Centre

Cannabis GMP insights from the institute

Regulation
What EU GMP Annex 1 (2022) means for cannabis manufacturers
Clause 4.4 mandates a Contamination Control Strategy for all medicinal product manufacturers — including non-sterile cannabis facilities. Here is what that means in practice.
Read article →
Cultivation
The GACP to GMP handover — where most facilities get it wrong
The transition from agricultural to pharmaceutical standards is the most critical and most frequently mismanaged boundary in the supply chain.
Read article →
Validation
Five cleaning validation failures inspectors find every time
PDE-based limits, swab recovery, worst-case sampling — five systematic gaps that appear in cannabis facilities repeatedly.
Read article →
View all articles and research
What practitioners say

What cannabis compliance professionals say about ECI

"The CCGP curriculum is the most practically grounded GMP training I have seen specifically for cannabis — built around our actual regulatory environment, not adapted from generic pharmaceutical content."
QM
Quality Manager
Licensed Cannabis Manufacturer, Portugal
"As a pharmacist advising on medical cannabis prescribing, the CCPS gave me the scientific and regulatory depth I needed to practise with confidence. Dr. Ribeiro's modules on cannabinoid pharmacology are exceptional."
CP
Clinical Pharmacist
Community Pharmacy, Spain
"The CCVP validation lifecycle module saved us weeks of work on our facility qualification programme. Having the cannabis-specific context built into the IQ/OQ/PQ framework is exactly what was missing."
VE
Validation Engineer
Cannabis Extraction Facility, Germany
"The Pharmaceuticalisation Index gave us an honest picture of where we stood. Uncomfortable in places, which is exactly the point. We used the output to structure our entire compliance investment for 2026."
SD
Site Director
Integrated Cannabis Producer, Netherlands

Testimonials from founding cohort members, 2026. Names withheld at request.

State of European Cannabis Compliance

The first pan-European primary research study into GMP readiness across the licensed cannabis sector. Takes 12 minutes. Results published Q4 2026. All participants receive the report.

Take the Survey Learn more